Treatment of congestive heart failure

Details Treatment of congestive heart failure Treatment of congestive heart failure

A - Human Necessities

61

K

A61K 31/675 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61K 31/40 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2075671

HA551 ABSTRACT TREATMENT OF CONGESTIVE HEART FAILURE Congestive heart failure is treated by administration of a selective inhibitor of neutral endopeptidase and an angiotensin converting enzyme inhibitor. Captopril, fosinopril sodium, enalapril maleate and lisinopril are the preferred angiotensin converting enzyme inhibitors and the mercapto compounds of the formula Image are the preferred selective inhibitors of neutral endopeptidase.

Affiliated with

Also associated with

Rating

Treatment of congestive heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of congestive heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of congestive heart failure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1378090